Who
Amy B. Summy
EVP, Chief Marketing Officer
Company insider
Files Form 4 as: EVP, Chief Marketing Officer, Labcorp Holdings.
In numbers
- Trades disclosed
- 96
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $2.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Mar 2020
- Last trade
- 4 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 6 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $283K924 at $306.74 | filing |
| 4 Aug 2026filed 6 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $283K924 at $306.74 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —3,994 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $493K1,836 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —3,994 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $493K1,836 at $268.38 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —230 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $24K83 at $289.89 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —230 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —230 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —230 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $24K83 at $289.89 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,900 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —620 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,900 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —620 at $0.00 | filing |
| 9 Feb 2026filed 10 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $22K80 at $274.01 | filing |
| 9 Feb 2026filed 10 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $22K80 at $274.01 | filing |
| 7 Feb 2026filed 10 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —222 | filing |
| 7 Feb 2026filed 10 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —222 at $0.00 | filing |
News
Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthLH · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Amy B. Summy; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.